Sierra Leone to Add Hepatitis B Birth Dose to Routine Immunisation Programme
Sierra Leone will introduce a free hepatitis B vaccine for newborns into its routine immunisation programme on 20 November 2026, targeting protection against early-life infection and mother-to-child...
Sierra Leone is scheduled to introduce a hepatitis B birth-dose vaccine into its national routine immunisation programme on 20 November 2026, giving newborns access to free protection at government health facilities across the country’s 16 districts.
Table Of Content
The Ministry of Health says the vaccine should ideally be given within the first 24 hours after birth. If that window is missed, vaccination is advised as soon as possible and within 72 hours.
The programme is intended to reduce infections acquired during childbirth and prevent mother-to-child transmission. All newborns will be eligible, including premature babies, babies with low birth weight and those born at home.
Routine protection from birth
The hepatitis B dose will be administered alongside the BCG and oral polio vaccines normally provided at birth. Unlike a temporary vaccination campaign, the new dose is being incorporated into Sierra Leone’s continuing routine immunisation services.
Sierra Leone has used hepatitis B-containing vaccines in its childhood immunisation programme since 2007. The existing schedule begins at six weeks, with additional doses at 10 and 14 weeks. The new birth dose is intended to provide earlier protection, particularly against infection transmitted during delivery.
Parents whose babies are born outside health facilities are being encouraged to take them immediately to the nearest government health facility. Major maternity hospitals, including Princess Christian Maternity Hospital in Freetown, are expected to provide the service.
Preparations and support
The Ministry of Health held a media engagement on 18 November with government officials, healthcare stakeholders, civil society organisations and journalists. Preparations have included community engagement, training for healthcare workers and improvements to vaccination services at maternity facilities.
WHO, UNICEF and Gavi are supporting the rollout. WHO is providing technical guidance, training, monitoring and assistance with immunisation policy. UNICEF is supporting procurement, supply-chain management, cold-chain systems and public education, while Gavi is supporting vaccine procurement and operational funding.
The Ministry of Health has also engaged mobile network operators to distribute public-information text messages. Parents and caregivers have been advised to keep immunisation cards and complete the full routine childhood vaccination schedule.
Health burden
According to figures attributed to the Ministry of Health, hepatitis B has a national prevalence rate of 13.8%, representing approximately 1.1 million people living with the infection. The ministry’s media brief also reported a 16.6% positivity rate among people aged 30 to 44 and said that five of the country’s 16 districts account for about half of the reported disease burden.
Hepatitis B affects the liver and can lead to cirrhosis, liver failure and liver cancer. The Ministry of Health says that up to 90% of babies infected during their first year of life may develop chronic infection. Dr Thompson Igbu, the Expanded Programme on Immunisation Lead at WHO Sierra Leone, said administering the birth dose within 24 hours is among the most effective ways to prevent mother-to-child transmission.
Professor Charles Senesie, Deputy Minister of Health, has estimated that Sierra Leone records about 400,000 births annually and that the programme is preparing to reach around 360,000 newborns. He also reported contributions of more than $240,000 from Gavi and approximately $60,000 from the Government of Sierra Leone, alongside staffing and infrastructure support.
The Ministry of Health says most babies experience no side effects from the vaccine. Some may develop mild pain or redness at the injection site or a slight fever. The vaccine prevents hepatitis B infection but does not treat people who are already infected. Suspected vaccine side effects can be reported through the national health emergency number, 117.
No Comment! Be the first one.